Citations for
1CCL2, GOLGA8B, IBTK, RAB26, SLC29A4, VEGFB
Negative correlation between endoglin levels and coronary atherosclerosis.
Chen H, Wang Y, Sun B, Bao X, Tang Y, Huang F, Zhu S, Xu J.
Lipids Health Dis Oct 3;20(1):127. doi: 10.1186/s12944-021-01545-2. 2021
2CCL2, TERF1
Age intrinsic loss of telomere protection via TRF1 reduction in endothelial cells.
Hohensinner PJ, Kaun C, Buchberger E, Ebenbauer B, Demyanets S, Huk I, Eppel W, Maurer G, Huber K, Wojta J.
Biochim Biophys Acta 1863(2):360-7. doi: 10.1016/j.bbamcr.2015.11.034. Epub 2015 Dec 1. 2016
3CCL2, F3, OLR1, TICAM1, TLR2
TRIF is a regulator of TLR2-induced foam cell formation.
Huang B, Park DW, Baek SH.
Mol Med Rep 14(4):3329-35. doi: 10.3892/mmr.2016.5647. Epub 2016 Aug 19. 2016
4CCL2, FLI1
Fli-1 controls transcription from the MCP-1 gene promoter, which may provide a novel mechanism for chemokine and cytokine activation.
Lennard Richard ML, Nowling TK, Brandon D, Watson DK, Zhang XK.
Mol Immunol 63(2):566-73. doi: 10.1016/j.molimm.2014.07.013. Epub 2014 Aug 6. 2015
5CCL14, CCL2, CCL3
Chemokines CCL2, 3, 14 stimulate macrophage bone marrow homing, proliferation, and polarization in multiple myeloma.
Li Y, Zheng Y, Li T, Wang Q, Qian J, Lu Y, Zhang M, Bi E, Yang M, Reu F, Yi Q, Cai Z.
Oncotarget 6(27):24218-29. 2015
6CCL2
Insulin resistance is associated with MCP1-mediated macrophage accumulation in skeletal muscle in mice and humans.
Patsouris D, Cao JJ, Vial G, Bravard A, Lefai E, Durand A, Durand C, Chauvin MA, Laugerette F, Debard C, Michalski MC, Laville M, Vidal H, Rieusset J.
PLoS One 9(10):e110653. doi: 10.1371/journal.pone.0110653. eCollection 2014. 2014
7CCL2
The chemokine (C-C motif) ligand 2 in neuroinflammation and neurodegeneration.
Madrigal JL, Caso JR.
Adv Exp Med Biol 824:209-19. doi: 10.1007/978-3-319-07320-0_15. Review. 2014
8CCL2, FASLG
Monocyte chemoattractant protein-1 (MCP-1) regulates macrophage cytotoxicity in abdominal aortic aneurysm.
Wang Q, Ren J, Morgan S, Liu Z, Dou C, Liu B.
PLoS One 9(3):e92053. doi: 10.1371/journal.pone.0092053. eCollection 2014. 2014
9CCL2
CCL2 mediates anti-fibrotic effects in human fibroblasts independently of CCR2.
Kalderén C, Stadler C, Forsgren M, Kvastad L, Johansson E, Sydow-Bäckman M, Svensson Gelius S.
Int Immunopharmacol 20(1):66-73. doi: 10.1016/j.intimp.2014.02.020. Epub 2014 Feb 26. 2014
10CCL2, NR1D1
A circadian clock gene, Rev-erbα, modulates the inflammatory function of macrophages through the negative regulation of Ccl2 expression.
Sato S, Sakurai T, Ogasawara J, Takahashi M, Izawa T, Imaizumi K, Taniguchi N, Ohno H, Kizaki T.
J Immunol 192(1):407-17. doi: 10.4049/jimmunol.1301982. 2014
11CCL2, CCL3
Serum CCL2 and CCL3 as potential biomarkers for the diagnosis of oral squamous cell carcinoma.
Ding L, Li B, Zhao Y, Fu YF, Hu EL, Hu QG, Ni YH, Hou YY.
Tumour Biol 35(10):10539-46. doi: 10.1007/s13277-014-2306-1. Epub 2014 Jul 25. 2014
12CCL2, OLR1
Ox-LDL promotes migration and adhesion of bone marrow-derived mesenchymal stem cells via regulation of MCP-1 expression.
Zhang F, Wang C, Wang H, Lu M, Li Y, Feng H, Lin J, Yuan Z, Wang X.
Mediators Inflamm 2013:691023. doi: 10.1155/2013/691023. Epub 2013 Jul 17. 2013
13CCL2, TWIST1
Twist1 induces CCL2 and recruits macrophages to promote angiogenesis.
Low-Marchelli JM, Ardi VC, Vizcarra EA, van Rooijen N, Quigley JP, Yang J.
Cancer Res 73(2):662-71. doi: 10.1158/0008-5472.CAN-12-0653. 2013
14CCL2
Obesity promotes breast cancer by CCL2-mediated macrophage recruitment and angiogenesis.
Arendt LM, McCready J, Keller PJ, Baker DD, Naber SP, Seewaldt V, Kuperwasser C.
Cancer Res 73(19):6080-93. doi: 10.1158/0008-5472.CAN-13-0926. Epub 2013 Aug 19. 2013
15BCL6, CCL2, ZXDC
The zinc finger transcription factor ZXDC activates CCL2 gene expression by opposing BCL6-mediated repression.
Ramsey JE, Fontes JD.
Mol Immunol 56(4):768-80. doi: 10.1016/j.molimm.2013.07.001. Epub 2013 Aug 14. 2013
16CCL2, CCR2
Role of chemokine CCL2 and its receptor CCR2 in neurodegenerative diseases.
Bose S, Cho J.
Arch Pharm Res 36(9):1039-50. doi: 10.1007/s12272-013-0161-z. Epub 2013 Jun 15. Review. 2013
17CCL2, LPA, OLR1
MCP-1 binds to oxidized LDL and is carried by lipoprotein(a) in human plasma.
Wiesner P, Tafelmeier M, Chittka D, Choi SH, Zhang L, Byun YS, Almazan F, Yang X, Iqbal N, Chowdhury P, Maisel A, Witztum JL, Handel TM, Tsimikas S, Miller YI.
J Lipid Res 54(7):1877-83. doi: 10.1194/jlr.M036343. Epub 2013 May 10. 2013
18CCL2, NFKBIZ
IκBζ is a transcriptional key regulator of CCL2/MCP-1.
Hildebrand DG, Alexander E, Hörber S, Lehle S, Obermayer K, Münck NA, Rothfuss O, Frick JS, Morimatsu M, Schmitz I, Roth J, Ehrchen JM, Essmann F, Schulze-Osthoff K.
J Immunol 190(9):4812-20. doi: 10.4049/jimmunol.1300089. Epub 2013 Apr 1. 2013
19CCL2
Monocyte chemoattractant protein-1 is a mediator of the anabolic action of parathyroid hormone on bone.
Tamasi JA, Vasilov A, Shimizu E, Benton N, Johnson J, Bitel CL, Morrison N, Partridge NC.
J Bone Miner Res 28(9):1975-86. doi: 10.1002/jbmr.1933. 2013
20CCL2
MCP-1 expression is specifically regulated during activation of skeletal repair and remodeling.
Wu AC, Morrison NA, Kelly WL, Forwood MR.
Calcif Tissue Int 92(6):566-75. doi: 10.1007/s00223-013-9718-6. Epub 2013 Mar 5. 2013
21CCL2, CCL3
Epigenetic upregulation of CCL2 and CCL3 via histone modifications in infiltrating macrophages after peripheral nerve injury.
Kiguchi N, Kobayashi Y, Saika F, Kishioka S.
Cytokine 64(3):666-72. doi: 10.1016/j.cyto.2013.09.019. Epub 2013 Oct 14. 2013
22CCL2, CCR2
MCP-1/CCR2 interactions direct migration of peripheral B and T lymphocytes to the thymus during acute infectious/inflammatory processes.
Hodge DL, Reynolds D, Cerbán FM, Correa SG, Baez NS, Young HA, Rodriguez-Galan MC.
Eur J Immunol 42(10):2644-54. doi: 10.1002/eji.201242408. Epub 2012 Aug 15. 2012
23CCL2, CCR2
Chemokine CCL2 and its receptor CCR2 in the medullary dorsal horn are involved in trigeminal neuropathic pain.
Zhang ZJ, Dong YL, Lu Y, Cao S, Zhao ZQ, Gao YJ.
J Neuroinflammation 9:136. doi: 10.1186/1742-2094-9-136. 2012
24CCL2, CCR2
CCR2 acts as scavenger for CCL2 during monocyte chemotaxis.
Volpe S, Cameroni E, Moepps B, Thelen S, Apuzzo T, Thelen M.
PLoS One 7(5):e37208. doi: 10.1371/journal.pone.0037208. Epub 2012 May 17. 2012
25CCL2, TP53
p53 is an important regulator of CCL2 gene expression.
Tang X, Asano M, O'Reilly A, Farquhar A, Yang Y, Amar S.
Curr Mol Med 12(8):929-43. 2012
26ACKR2, CCL2, CCR2
CCL2 binding is CCR2 independent in primary adult human astrocytes.
Fouillet A, Mawson J, Suliman O, Sharrack B, Romero IA, Woodroofe MN.
Brain Res 1437:115-26. doi: 10.1016/j.brainres.2011.11.049. Epub 2011 Dec 4. 2012
27CCL2, PIK3CG
Key role of PI3Kγ in monocyte chemotactic protein-1-mediated amplification of PDGF-induced aortic smooth muscle cell migration.
Fougerat A, Smirnova NF, Gayral S, Malet N, Hirsch E, Wymann MP, Perret B, Martinez LO, Douillon M, Laffargue M.
Br J Pharmacol 166(5):1643-53. doi: 10.1111/j.1476-5381.2012.01866.x. 2012
28CCL2, HDAC2, HDAC3, MS4A2
Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.
Kim Y, Kim K, Park D, Lee E, Lee H, Lee YS, Choe J, Jeoung D.
J Biol Chem 287(31):25844-59. doi: 10.1074/jbc.M112.348284. Epub 2012 Jun 7. 2012
29CCL2, EDN1, IL6
Endothelin-1 increases collagen accumulation in renal mesangial cells by stimulating a chemokine and cytokine autocrine signaling loop.
Simonson MS, Ismail-Beigi F.
J Biol Chem 286(13):11003-8. Epub 2010 Dec 17. 2011
30CCL2, CCR2
CCL2 released from neuronal synaptic vesicles in the spinal cord is a major mediator of local inflammation and pain after peripheral nerve injury.
Van Steenwinckel J, Reaux-Le Goazigo A, Pommier B, Mauborgne A, Dansereau MA, Kitabgi P, Sarret P, Pohl M, Mélik Parsadaniantz S.
J Neurosci 31(15):5865-75. 2011
31CCL2
CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis.
Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR, Kaiser EA, Snyder LA, Pollard JW.
Nature 475(7355):222-5. doi: 10.1038/nature10138. 2011
32CCL2, F3
Tissue factor regulates microvessel formation and stabilization by induction of chemokine (C-C motif) ligand 2 expression.
Arderiu G, Peña E, Aledo R, Juan-Babot O, Badimon L.
Arterioscler Thromb Vasc Biol 31(11):2607-15. doi: 10.1161/ATVBAHA.111.233536. 2011
33CCL2, CCL3, CCL4, CCL5
Adiponectin stimulates release of CCL2, -3, -4 and -5 while the surface abundance of CCR2 and -5 is simultaneously reduced in primary human monocytes.
Neumeier M, Bauer S, Brühl H, Eisinger K, Kopp A, Abke S, Walter R, Schäffler A, Buechler C.
Cytokine 56(3):573-80. doi: 10.1016/j.cyto.2011.08.017. Epub 2011 Sep 3. Erratum in: Cytokine. 2013 Jun;62(3):453. 2011
34CCL2, ZC3H12A
MCP-1 causes cardiomyoblast death via autophagy resulting from ER stress caused by oxidative stress generated by inducing a novel zinc-finger protein, MCPIP.
Younce CW, Kolattukudy PE.
Biochem J 426(1):43-53.PMID: 19925454 2010
35CCL2, CMTX1
Attenuation of MCP-1/CCL2 expression ameliorates neuropathy in a mouse model for Charcot-Marie-Tooth 1X.
Groh J, Heinl K, Kohl B, Wessig C, Greeske J, Fischer S, Martini R.
Hum Mol Genet 19(18):3530-43. Epub 2010 Jun 30.PMID: 20591826 2010
36CCL2, RAC1
Monocyte chemoattractant protein-1/CC chemokine ligand 2 enhances apoptotic cell removal by macrophages through Rac1 activation.
Tanaka T, Terada M, Ariyoshi K, Morimoto K.
Biochem Biophys Res Commun 399(4):677-82. Epub 2010 Aug 5.PMID: 20691665 2010
37CCL2, CCR2
The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases.
Conductier G, Blondeau N, Guyon A, Nahon JL, Rovère C.
J Neuroimmunol 224(1-2):93-100. Review. 2010
38CCL2
Association of monocyte chemoattractant protein 1 gene polymorphism with susceptibility to nonfamilial idiopathic dilated cardiomyopathy.
Ogimoto A, Okayama H, Nagai T, Ohtsuka T, Suzuki J, Inoue K, Nishimura K, Shigematsu Y, Tabara Y, Kohara K, Miki T, Higaki J.
J Cardiol 54(1):66-70. Epub 2009 May 13. 2009
39CCL2
MCP-1 expressed by osteoclasts stimulates osteoclastogenesis in an autocrine/paracrine manner.
Miyamoto K, Ninomiya K, Sonoda KH, Miyauchi Y, Hoshi H, Iwasaki R, Miyamoto H, Yoshida S, Sato Y, Morioka H, Chiba K, Egashira K, Suda T, Toyama Y, Miyamoto T.
Biochem Biophys Res Commun 383(3):373-7. Epub 2009 Apr 11. 2009
40CCL2, CXCL10
Cleavage of chemokines CCL2 and CXCL10 by matrix metalloproteinases-2 and -9: implications for chemotaxis.
Denney H, Clench MR, Woodroofe MN.
Biochem Biophys Res Commun 382(2):341-7. Epub 2009 Mar 10.PMID: 19281798 2009
41CCL2, CCR2
Activation of MCP-1/CCR2 axis promotes prostate cancer growth in bone.
Lu Y, Chen Q, Corey E, Xie W, Fan J, Mizokami A, Zhang J.
Clin Exp Metastasis 26(2):161-9. Epub 2008 Nov 11. 2009
42CCL2,TGFB1
MCP-1 mediates TGF-beta-induced angiogenesis by stimulating vascular smooth muscle cell migration.
Ma J, Wang Q, Fei T, Han JD, Chen YG.
Blood 109(3):987-94. Epub 2006 Oct 10. 2007
43CCL2,CCR2,NUP85
A novel activator of C-C chemokine, FROUNT, is expressed with C-C chemokine receptor 2 and its ligand in failing human heart.
Satoh M, Akatsu T, Ishkawa Y, Minami Y, Nakamura M.
J Card Fail 13(2):114-9. 2007
44CCL2
The CC chemokine ligand 2 (CCL2) mediates fibroblast survival through IL-6.
Liu X, Das AM, Seideman J, Griswold D, Afuh CN, Kobayashi T, Abe S, Fang Q, Hashimoto M, Kim H, Wang X, Shen L, Kawasaki S, Rennard SI.
Am J Respir Cell Mol Biol 37(1):121-8. Epub 2007 Mar 22. 2007
45CCL2,CCR2
Monocyte chemoattractant protein (MCP-1) is expressed in human cardiac cells and is differentially regulated by inflammatory mediators and hypoxia.
Hohensinner PJ, Kaun C, Rychli K, Ben-Tal Cohen E, Kastl SP, Demyanets S, Pfaffenberger S, Speidl WS, Rega G, Ullrich R, Maurer G, Huber K, Wojta J.
FEBS Lett 580(14):3532-8. Epub 2006 May 24. 2006
46CCL2,CCR2
The expression of monocyte chemoattractant protein-1 and C-C chemokine receptor 2 in post-kidney transplant patients and the influence of simvastatin treatment.
Wang J, Zou H, Li Q, Wang Y, Xu Q.
Clin Chim Acta 373(1-2):44-8. Epub 2006 May 12. 2006
47CCL2
Monocyte chemotactic protein-1 (MCP-1) acts as a paracrine and autocrine factor for prostate cancer growth and invasion.
Lu Y, Cai Z, Galson DL, Xiao G, Liu Y, George DE, Melhem MF, Yao Z, Zhang J.
Prostate 66(12):1311-8. 2006
48CCL2
A functional promoter polymorphism in monocyte chemoattractant protein-1 is associated with increased susceptibility to pulmonary tuberculosis.
Flores-Villanueva PO, Ruiz-Morales JA, Song CH, Flores LM, Jo EK, Montano M, Barnes PF, Selman M, Granados J.
J Exp Med 202(12):1649-58. Epub 2005 Dec 13. 2005
49CCL2
Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue.
Henkel JS, Engelhardt JI, Siklos L, Simpson EP, Kim SH, Pan T, Goodman JC, Siddique T, Beers DR, Appel SH.
Ann Neurol 55(2):221-35. 2004
50CCL2
MCP-1 promoter polymorphism in Spanish patients with rheumatoid arthritis.
Gonzalez-Escribano MF, Torres B, Aguilar F, Rodriguez R, Garcia A, Valenzuela A, Nunez-Roldan A.
Hum Immunol 64(7):741-4. 2003
51CCL2
A novel MCP-1 gene polymorphism is associated with hepatic MCP-1 expression and severity of HCV-related liver disease.
Muhlbauer M, Bosserhoff AK, Hartmann A, Thasler WE, Weiss TS, Herfarth H, Lock G, Scholmerich J, Hellerbrand C.
Gastroenterology 125(4):1085-93. 2003
52CCL2
Upregulation of monocyte chemoattractant protein 1 and effects of transforming growth factor-beta 1 in Peyronie's disease.
Lin CS, Lin G, Wang Z, Maddah SA, Lue TF.
Biochem Biophys Res Commun 295(4):1014-9. 2002
53CCL2
A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression.
Rovin BH, et al.
Biochem Biophys Res Commun 259(2):344-8. 1999
54CCL2
Monocyte chemoattractant protein 1 (MCP-1) gene expression in dilated cardiomyopathy.
Lehmann MH, Kuhnert H, Muller S, Sigusch HH.
Cytokine 10 : 739-746. 1998
55CCR2, JAK2, CCL2
The chemokine monocyte chemotactic protein 1 triggers Janus kinase 2 activation and tyrosine phosphorylation of the CCR2B receptor.
Mellado M, Rodriguez-Frade JM, Aragay A, del Real G, Martin AM, Vila-Coro AJ, Serrano A, Mayor F Jr, Martinez-A C.
J Immunol 161(2):805-13. 1998
56CCL2, CCL8
Posttranslational modifications affect the activity of the human monocyte chemotactic proteins MCP-1 and MCP-2: identification of MCP-2(6-76) as a natural chemokine inhibitor.
Proost P, Struyf S, Couvreur M, Lenaerts JP, Conings R, Menten P, Verhaert P, Wuyts A, Van Damme J.
J Immunol 160(8):4034-41. 1998
57CCL2
Assignment of the human small inducible cytokine A2 gene, SCYA2 (encoding JE or MCP-1), to 17q11.2-12 : evolutionary relatedness of cytokines clustered at the same locus.
Rollins BJ, et al.
Genomics 10 : 489-492. 1991
58CCL2
Localization of monocyte chemotactic protein-1 gene (SCYA2) to human chromosome 17q11.2-q21.1.
Mehrabian M, et al.
Genomics 9 : 200-203. 1991
59CCL1, CCL2
Structure of human monocyte chemotactic protein gene and its regulation by TPA.
Shyy YJ, et al.
Biochem Biophys Res Commun 169 : 346-351. 1990